2021
DOI: 10.1016/j.intimp.2021.108150
|View full text |Cite
|
Sign up to set email alerts
|

Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue

Abstract: The etiological agent of coronavirus disease (COVID-19) is the new member of the Coronaviridae family, a severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2), responsible for the pandemic that is plaguing the world. The single-stranded RNA virus is capable of infecting the respiratory tract, by binding the spike (S) protein on its viral surface to receptors for the angiotensin II-converting enzyme (ACE2), highly expressed in the pulmonary tissue, enabling the interaction of the virus with alveola… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 195 publications
(216 reference statements)
0
5
0
Order By: Relevance
“…There is growing appreciation that targeting purinergic receptors may bring benefit to treat SARS-CoV-2 induced processes associated with the pathologies of COVID-19 (216)(217)(218)(219)(220)(221)(222). Accumulated clues to the puzzle of SARS-CoV-2 have suggested that when a virus can initiate platelet and neutrophil driven exacerbated macrophage inflammatory circuits, this can spell a pandemic.…”
Section: Discussionmentioning
confidence: 99%
“…There is growing appreciation that targeting purinergic receptors may bring benefit to treat SARS-CoV-2 induced processes associated with the pathologies of COVID-19 (216)(217)(218)(219)(220)(221)(222). Accumulated clues to the puzzle of SARS-CoV-2 have suggested that when a virus can initiate platelet and neutrophil driven exacerbated macrophage inflammatory circuits, this can spell a pandemic.…”
Section: Discussionmentioning
confidence: 99%
“…Many published studies have demonstrated the importance of the purinergic system in the inflammation associated with the cytokine storm caused by moderate/ severe infection, including COVID-19, and have shown that using various purinergic system receptors as a therapeutic target can limit the negative effects of the cytokine storm [21,22,[55][56][57]. Extracellular ATP at high concentrations becomes a true alarmin [58], a potent proinflammatory signal capable of overexpressing and stimulating P2X-type purinergic receptors, especially P2X7R, located on various immune cells (neutrophils, eosinophils, monocytes, macrophages, mast cells, and lymphocytes) [59].…”
Section: Discussionmentioning
confidence: 99%
“…Column chromatography of the products was performed with a CombiFlash R f Companion System using RediSep packed columns. 1 H-and 13 C-NMR data were collected on a Bruker Avance 500 MHz NMR spectrometer (Bruker Corporation, Billerica, MA, USA)at 500 MHz ( 1 H), and 126 MHz ( 13 C), or on a Bruker Avance 600 MHz NMR spectrometer (Bruker, Karlsruhe, Germany) at 600 MHz ( 1 H), and 151 MHz ( 13 C). DMSO-d 6 was used as solvent.…”
Section: Generalmentioning
confidence: 99%
“…Moreover, A2A-and especially A2BARs are often upregulated on canc cells contributing to enhanced proliferation, metastasis, and angiogenesis [10][11][12]. Ther fore, A2A-and A2BAR antagonists, including dual-acting compounds that block both A subtypes, have been developed and are currently evaluated in clinical trials for canc immunotherapy [13]. According to the Protein Data Bank (PDB) [14], 60 X-ray cryst structures of the human A2AAR in complex with 20 different antagonists [15] (and 5 ag nists) have been published up to now, while structural data for the A2BAR are still elusiv However, X-ray co-crystal structures of the A2BAR in complex with antagonists would b highly useful in order to understand their binding and interactions.…”
Section: Introductionmentioning
confidence: 99%